Pfizer and BioNTech have begun a clinical trial for an Omicron-specific Covid-19 vaccine candidate. But Dr. Luis Schang, a virologist at Cornell University, says while it makes sense to develop a specific vaccine against Omicron, we should not lose sight of what is already available.
Public health practitioner Julie Edwards, MHA has joined Cornell Health as the new director of the Skorton Center for Health Initiatives, a department providing university leadership for addressing college health concerns including alcohol misuse, hazing, suicide, sexual violence and bias.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.
New nanophotonic tweezers developed by Cornell researchers can stretch and unzip DNA molecules as well as disrupt and map protein-DNA interactions, paving the way for commercial availability.
A study also revealed that expanded duties, particularly emotional care, resulted in a higher perceived value of the workers’ contributions, which could help boost pay for home care workers.
Dr. Kelly Musick, a Brooks School of Public Policy work-family researcher, has won a prestigious award for an article she co-authored that analyzed earnings patterns after the birth of a child.
As the world enters a third year of pandemic-related uncertainties, one thing does seem certain: The SARS-CoV-2 virus mutates and keeps us on our toes.
A new Cornell-led project will accelerate the application of a proven biotechnology to enhance food and nutritional security in Bangladesh and the Philippines while protecting the health of farmers and the environment.
A new study finds that despite increasing numbers of bald eagles, poisoning from eating dead carcasses or parts contaminated by lead shot has reduced population growth by 4% to 6% annually in the Northeast.
